Arch Oncology

Arch Oncology is a clinical-stage biopharmaceutical company dedicated to the development of novel therapies for patients with hematologic malignancies and solid tumors. Their primary focus is on discovering and developing novel immunotherapies and targeted therapies that address significant unmet needs in the treatment of these cancers. Their lead program, ARCH-301, is a novel, highly potent and selective anti-TIGIT antibody currently being investigated in a Phase 1/2 clinical trial for patients with advanced solid tumors and hematologic malignancies.

Arch Oncology is committed to building a diverse and inclusive workplace where all employees feel valued and empowered. They believe in fostering a culture of collaboration and innovation, where everyone has the opportunity to contribute to their mission of bringing life-changing therapies to patients. They are dedicated to attracting and retaining top talent from a variety of backgrounds and experiences.

Arch Oncology offers a flexible work environment, allowing employees to work from home. The company embraces a hybrid work model that enables employees to work from the office or remotely, fostering a healthy work-life balance. This flexibility is demonstrated through the company's embrace of virtual technology and commitment to providing employees with the necessary resources to work effectively from any location.

Arch Oncology offers a competitive benefits package designed to support the well-being of its employees. Benefits include comprehensive medical, dental, and vision insurance, along with life insurance and disability coverage. Employees also have access to a 401(k) retirement plan with a company match, generous paid time off, and paid parental leave. Additionally, the company provides flexible work arrangements, tuition reimbursement, and employee assistance programs, demonstrating its commitment to employee growth and overall wellness.

Arch Oncology is a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for patients with difficult-to-treat cancers. They focus on advancing novel therapies that target the tumor microenvironment, aiming to improve treatment outcomes and improve the lives of cancer patients.

Arch Oncology fosters a collaborative and inclusive culture that values scientific rigor, innovation, and a shared commitment to improving the lives of cancer patients. They prioritize teamwork, open communication, and a growth mindset, encouraging employees to contribute their unique perspectives and strive for excellence in all they do.

Arch Oncology is committed to fostering a diverse, equitable, and inclusive workplace, believing that a broad range of perspectives and experiences contribute to their mission of advancing therapies for patients with cancer. They actively seek to build a team that reflects the diversity of the communities they serve, promoting equal opportunity for all employees and creating a culture of respect and belonging.